| 发明名称 | Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders | ||
| 摘要 | The described invention provides methods and kits for administering an EPO-derived peptide to a subject suffering from a neurodegenerative disease. The EPO-derived peptide delays the onset and/or progression of a neurodegenerative disease, limits cognitive impairment in, and prolongs the survival of, subjects suffering from a neurodegenerative disease. | ||
| 申请公布号 | US9585932(B2) | 申请公布日期 | 2017.03.07 |
| 申请号 | US201313792336 | 申请日期 | 2013.03.11 |
| 申请人 | Dowling Peter C. | 发明人 | Lu Wei;Dowling Peter C.;Yuan Rui Rong |
| 分类号 | A61K38/00;C07K14/505;A61K38/10;A61K38/18 | 主分类号 | A61K38/00 |
| 代理机构 | Locke Lord LLP | 代理人 | Zerhusen Bryan D.;Locke Lord LLP |
| 主权项 | 1. A kit comprising a composition comprising a cyclic EPO-derived peptide of SEQ ID NO: 1. | ||
| 地址 | Fort Lee NJ US | ||